New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Cronos Group Inc.
CRON.TO
Shape
US Flag

TSX

Unprofitable

Unprofitable

1B

Drug Manufacturers - Specialty & Generic

Next Earning date - 06 Nov 2024

1B

Drug Manufacturers - Specialty & Generic

Next Earning date - 06 Nov 2024

3.11CAD
Shape0.06 ( 1.97%)
Market Open
favorite-chart

Relative Strenght

favorite-chart

Volume Buzz

-38%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

27%

Quote Panel

Shape
Updated October 28, 2024
1W -0.64 % 1M 4.01 % 3M -6.04 % 1Y 26.94 %

Key Metrics

Shape
  • Market Cap

    1.19B


  • Shares Outstanding

    382.28M


  • Share in Float

    200.31M


  • Dividende

    0


  • Earning Date

    06 Nov 2024


  • Price Target

    3.11


  • Average Volume

    102162


  • Beta

    1.024


  • Range

    2.36-4.28


  • Industry

    Drug Manufacturers - Specialty & Generic


  • Website

    https://www.thecronosgroup.com


  • Sector

    Healthcare


Fundamentals

Shape

N/A

P/E Ratio

8.41x

P/S Ratio

0.81x

P/B Ratio

0.0

Debt/Equity

-56.4%

Net Margin

$-0.2

EPS

How CRON.TO compares to sector?

P/E Ratio

Relative Strength

Shape

CRON.TO

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$129M

Shape363%

2025-Revenue

$0.03

Shape-28%

2025-EPS

$67M

Shape-2175%

2025-EBITDA

Analyst rating

No Data Available

Last analyst upgrade/downgrade

No Data Available

Earnings GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

N/A

-0.10
vs 0.21

Q4.22

arrow
arrow

N/A

-0.21
vs -0.36

Q1.23

arrow
arrow

N/A

-0.05
vs -0.09

Q2.23

arrow
arrow

N/A

-0.01
vs -0.05

Q3.23

arrow
arrow

N/A

-0.00
vs -0.10

Q4.23

arrow
arrow

N/A

-0.07
vs -0.21

Q1.24

arrow
arrow

N/A

-0.01
vs -0.05

Q2.24

arrow
arrow

N/A

-0.02
vs -0.01

Q3.24

arrow
arrow

+257%

0.01
vs -0.00

Q4.24

arrow
arrow

+106%

0
vs -0.07

Sales GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

+3%

20.9M  vs 20.4M

Q4.22

arrow
arrow

-11%

22.9M  vs 25.8M

Q1.23

arrow
arrow

-20%

20.1M  vs 25M

Q2.23

arrow
arrow

-18%

19M  vs 23.1M

Q3.23

arrow
arrow

+19%

24.8M  vs 20.9M

Q4.23

arrow
arrow

+4%

23.9M  vs 22.9M

Q1.24

arrow
arrow

+26%

25.3M  vs 20.1M

Q2.24

arrow
arrow

+46%

27.8M  vs 19M

Q3.24

arrow
arrow

+67%

41.4M  vs 24.8M

Q4.24

arrow
arrow

+83%

43.9M  vs 23.9M

Return on EquityShape

status-upQoQ

Q3.22

arrow
arrow

-3%

-0.03
vs -0.02

Q4.22

arrow
arrow

-7%

-0.07
vs -0.03

Q1.23

arrow
arrow

-2%

-0.02
vs -0.07

Q2.23

arrow
arrow

-1%

-0.01
vs -0.02

Q3.23

arrow
arrow

0%

-0.00
vs -0.01

Q4.23

arrow
arrow

-4%

-0.04
vs -0.00

Q1.24

arrow
arrow

0%

-0.00
vs -0.04

Q2.24

arrow
arrow

-1%

-0.01
vs -0.00

Institutionnal OwnershipShape

status-up

Earnings Growth

Latest News